Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Place de la chimiothérapie dans le traitement des tumeurs de l’ovaire à la limite de la malignité

  • Chapter
Les cancers ovariens

Part of the book series: Abord clinique ((ONCOLPRAT))

  • 319 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Tropé C, Kaern J (1998) Management of borderline tumors of the ovary: State of the art. Semin Oncol, 25: 372–80

    PubMed  Google Scholar 

  2. Elchalal U, Dgani R, Piura B et al. (1995) Current concepts in management of epithelial ovarian tumors of low malignant potential. Obstet Gynecol Surv 50(1): 62–70

    Article  CAS  PubMed  Google Scholar 

  3. Kaern J, Tropé CG, Abeler VM (1993) A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982. A review of clinicopathologic features and treatment modalities. Cancer 71(5): 1810–20

    CAS  PubMed  Google Scholar 

  4. Burger CW, Prinssen HM, Baak JPA et al. (2000) The management of borderline epithelial tumors of the ovary. Int J Gynecol Cancer 10: 181–97

    Article  PubMed  Google Scholar 

  5. Tamakoshi K, Kikkawa F, Nakashima N et al. (1997) Clinical behaviour of borderline ovarian tumors: A Study of 150 cases. J Surg Oncol 64: 147–52

    Article  CAS  PubMed  Google Scholar 

  6. Zanetta G, Rota S, Chiari S et al. (2001). Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study. J Clin Oncol 19(10): 2658–64

    CAS  PubMed  Google Scholar 

  7. Leake J, Currie J, Rosenshein N et al. (1992) Long-term follow-up of serous ovarian tumors of low malignant potential. Gynecol Oncol 47: 150–8

    Article  CAS  PubMed  Google Scholar 

  8. Chambers JT (1989) Borderline ovarian tumors: a review of treatment. Yale J. Biol. Med., 62: 351–65

    CAS  PubMed  Google Scholar 

  9. Tropé C, Kaern J, Vergote IB et al. (1993) Are borderline tumors of the ovary overtreated TOLMh surgically and systemically? A review of four prospective randomized trials including 253 patients with borderline tumors. Gynecol Oncol 51: 236–43

    Article  PubMed  Google Scholar 

  10. Kurman RJ, Trimble CL (1993) The behavior of serous tumors of low malignant potential: are they ever malignant? Int J Gynecol Pathol 12: 120–7

    CAS  PubMed  Google Scholar 

  11. Tropé CG, Kristensen G, Makar A (2000) Surgery for borderline tumor of the ovary. Semin Surg Oncol 19(1): 69–75

    Article  PubMed  Google Scholar 

  12. Lim-Tan S, Cajigas H, Scully R (1988) Ovarian cystectomy for serous borderline. tumors: a follow-up study of 35 cases. Obstet Gynecol 72: 775–80

    CAS  PubMed  Google Scholar 

  13. Darai E, Teboul J, Fauconnier A (1998 a) Management and outcome of borderline ovarian tumors indicentally discovered at or after laparoscopy. Acta Obstet Gynecol Scand 77: 451–7

    Article  CAS  PubMed  Google Scholar 

  14. Morice P, Camatte S, El Hassan J et al. (2001) Clinical outcomes and fertility results after conservative treatment for ovarian borderline tumor. Fertil Steril 75: 92–6

    Article  CAS  PubMed  Google Scholar 

  15. Gershenson D, Silva E, Levy L (1998 a) Ovarian Serous Borderline Tumors with Invasive Peritoneal Implants. Cancer 82: 1096–103

    Article  CAS  PubMed  Google Scholar 

  16. Gershenson D, Silva EL, Tortolero-Luna G (1998 b) Serous Borderline Tumors of the Ovary with Non invasive Peritoneal Implants. Cancer 83: 2157–63

    Article  CAS  PubMed  Google Scholar 

  17. Morice S, Camatte A, Rey D et al. (2002) Prognostic factors of patients with advanced stage serous borderline tumors of the ovary. Ann Oncol 14: 592–8

    Google Scholar 

  18. Piura B, Dgani R, Blickstein et al. (1992) Epithelial ovarian tumors of borderline malignancy: a study of 50 cases. Int J Gynecol Cancer 2: 189–95

    Article  PubMed  Google Scholar 

  19. Hsu YK, Parmely TH, Rosenhein NB et al. (1987) Neoplastic and nonneoplas-tic.mesothelioma proliferations in ovarian tumors of low malignant potential. Obstet Gynecol 770: 923–31

    Google Scholar 

  20. Crispens MA, Bodurka D, Deavers M et al. (2002) Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential. Obstet Gynecol 99(1): 3–10

    Article  PubMed  Google Scholar 

  21. Camatte S, Morice P, Pautier P et al. (2002) Fertility results after conservative treatment of advanced stage serous borderline tumors of the ovary. BJOG 109: 376–80

    PubMed  Google Scholar 

  22. Bell DA, Weinstock RA, Scully R (1988) Peritoneal implants of ovarian serous borderline tumors:histologic features and prognosis. Cancer 62: 2212–22

    CAS  PubMed  Google Scholar 

  23. Seidman J, Kurman R (1996) Subclassification of serous borderline tumors of the ovary into begnin and malignant types: a clinicopathologic study of 65 advanced stage cases. Am J Surg Pathol 20: 1331–45

    CAS  PubMed  Google Scholar 

  24. Casey AC, Bell DA, Lage JM et al. (1993) Epithelial ovarian tumors of borderline malignancy: long-term follow-up. Gynecol Oncol 50: 316–22

    Article  CAS  PubMed  Google Scholar 

  25. Parker RL, Clement PB, Chercover DJ et al. (2004) Early recurrence of ovarian serous borderline tumor as high-grade carcinoma: a report of two cases. Int J Gynecol Pathol 23(3): 265–72

    PubMed  Google Scholar 

  26. Morice P, Thoury A, Sabourin JC et al. (2003) Spontaneous regression of peritoneal implants in borderline ovarian tumor after salpingo-oophorectomy. J Clin Oncol 21: 3536–8

    Article  CAS  PubMed  Google Scholar 

  27. Taylor HC, Alson WE (1932) Spontaneous regression of peritoneal implantations from ovarian papillary cystadenoma. Am J Cancer 16: 1305–25

    Google Scholar 

  28. Trimble CL, Kosary C, Trimble EL (2002) Long-term survival and patterns of care in women with ovarian tumors of low malignant potential. Gynecol Oncol 86: 34–7

    Article  PubMed  Google Scholar 

  29. Gersherson DM, Silva EG (1990) Serous ovarian tumors of low malignant potential with peritoneal implants. Cancer 65: 578–85

    Google Scholar 

  30. Michael H, Sutton G, Roth L (1987) Ovarian carcinoma with extracellular mucin production: reassessment of « pseudomyxoma ovarii et peritonei ». Int J Gynecol Pathol 6: 298–310

    CAS  PubMed  Google Scholar 

  31. Leake JF, Ader JS, Woodruff JD (1991) Retroperitoneal lymphatic involvement with epithelial ovarian tumors of low malignant potential. Gynecol Oncol 42: 124–30

    Article  CAS  PubMed  Google Scholar 

  32. Tan LK, Flynn SD, Carcangiu ML (1994) Ovarian serous borderline tumors with lymph node involvement: clinicopathologic and DNA content study of seven cases and review of the litterature. Am J Surg Pathol 18: 904–12

    CAS  PubMed  Google Scholar 

  33. Camatte S, Morice P, Atallah D et al. (2002) Lymph node disorders and prognostic value of nodal involvement in patients treated for borderline ovarian tumor: An analysis of a series of 42 lymphadénectomies. J Am Coll Surg 195: 332–8

    Article  PubMed  Google Scholar 

  34. Yoonesi M, Crickard K, Celik C et al. (1988). Borderline epithelial tumors of the ovary: ovarian intraepithelial neoplasia. Obstet Gynecol Survey 43(8): 435–44

    Google Scholar 

  35. Michel G, Rochard F, Prade M et al. (1994) Incidence and prognosis of intraoperative rupture of borderline ovarian tumours. In: Bruhat MA The management of adnexal cysts. Blackwell, Oxford, pp 116–21

    Google Scholar 

  36. Kennedy AW, Hart WR (1996) Ovarian papillary serous tumors of low malignant poten-tial (serous borderline tumors). A long term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma. Cancer 78: 278–86

    Article  CAS  PubMed  Google Scholar 

  37. Beller U, Bigelow B, Beckman EM et al. (1983) Epithelial carcinoma of the ovary in the reproductive years: clinical and morphological characterization. Gynecol Oncol 15: 422–6

    Article  CAS  PubMed  Google Scholar 

  38. Tavasolli FA (1988) Serous tumor of low malignant potential with early stromal invasion (serous LMP with micro-invasion). Mod Pathol 1: 407–13

    Google Scholar 

  39. Hoerl HD, Hart WR (1998) Primary ovarian mucinous cystadenocarcinomas: a clinicopathologic study of 49 cases with long-term follow-up. Am J Surg Pathol 22(12): 1449–62

    Article  CAS  PubMed  Google Scholar 

  40. Darai E, Walker-Combrouze F, Mlika-Cabanne N et al. (1998 b) Expression of p53 protien in borderline epithelial ovarian tumors: a clinicopathologic study of 39 cases. Eur J Gynecol Oncol 19: 144–9

    CAS  Google Scholar 

  41. Eltabbakh GH, Belinson JL, Kennedy AW et al. (1997) P53 and HER-2/neu overexpression in ovarian borderline tumors. Gynecol Oncol 65: 218–242

    Article  CAS  PubMed  Google Scholar 

  42. Gershenson D, Deavers M, Diaz S et al. (1999) Prognostic significance of p53 expression in advanced-stage ovarian serous borderline tumors. Clin Cancer Res 5: 4053–8

    CAS  PubMed  Google Scholar 

  43. Friedlander ML, Hedley DW, Swanson C et al. (1988) Prediction of long-term survival by flow cytometric analysis of cellular DNA content in patients with advanced ovarian cancer. Clin Oncol 6(2): 282-90

    Google Scholar 

  44. De Nictolis M, Montironi R, Tommasoni S et al. (1992) Serous borderline tumors of the ovary. A clinicopathologic, immunohistochemical, and quantitative study of 44 cases. Cancer 70:152–60

    PubMed  Google Scholar 

  45. McCaughey WT, Kirk ME, Lester W (1984) Peritoneal epithelial lesions associated with proliferative serous tumours of ovary. Histopathology 8:195–208

    CAS  PubMed  Google Scholar 

  46. Michael H, Roth LM (1986) Invasive and noninvasive implants in ovarian serous tumors of low malignant potential. Cancer 57:1240–7

    CAS  PubMed  Google Scholar 

  47. Gershenson DM (2002) Is micropapillary serous carcinoma for real? Cancer 15: 95(4): 677-80. Comment on: Cancer 2002 Aug 15; 95(4): 791-800

    Google Scholar 

  48. Piura B, Rabinovich A, Yanai-Inbar I (2000) Micropapillary serous carcinoma of the ovary: case report and review of literature. Eur J Gynaecol Oncol 21(4): 374–6

    CAS  PubMed  Google Scholar 

  49. Young RC, Walton LA, Ellenberg SS et al. (1990) Adjuvant therapy in stage I and II epithelial ovarian cancer. Results of two prospective randomized trials. N Engl J Med 322: 1021–7

    CAS  PubMed  Google Scholar 

  50. Creasman WT, Park R, Norris H et al. (1982) Stage I borderline ovarian tumors. Obstet Gynecol 59: 93–6

    CAS  PubMed  Google Scholar 

  51. Lackman F, Carey MS, Kirk ME et al. (2003) Surgery as sole treatment for serous borderline tumors of the ovary with noninvasive implants. Gynecol Oncol 90(2): 407–12

    Article  CAS  PubMed  Google Scholar 

  52. Prat J (1999) Ovarian tumors of borderline malignancy (tumors of low malignant potential): a critical appraisal. Adv Anat Pathol 6(5): 247–74

    CAS  PubMed  Google Scholar 

  53. Yazigi R, Munoz AK, Sandstad J et al. (1991) Cisplatin-based combination chemotherapy in the treatment of stage III ovarian epithelial tumors of low malignant potential. Eur J Gynecol Oncol 12(6): 451–5

    CAS  Google Scholar 

  54. Sutton GP, Bundy BN, Omura GA et al. (1991) Stage III ovarian tumors of low malignant potential treated with cisplatin combination therapy (a Gynecologic Oncology Group study). Gyn Oncol 41: 230–3

    Article  CAS  Google Scholar 

  55. Eltabbakh GH, Srivastava A, Garafano LL (2000) Surgical response of advanced-stage borderline ovarian tumors to paclitaxel and cisplatin chemotherapy. Gynecol Oncol 77: 343–4

    Article  CAS  PubMed  Google Scholar 

  56. Bostwick DG, Tazelaar HD, Ballon SC et al. (1986) Ovarian epithelial tumors of borderline malignancy. A clinical and pathologic study of 109 cases. Cancer 58: 2052–65

    CAS  PubMed  Google Scholar 

  57. Barnhill D, Heller P, Brzozowski P et al. (1985) Epithelial ovarian carcinoma of low malignant potential. Obstet Gynecol 65(1): 53–9

    CAS  PubMed  Google Scholar 

  58. Kliman L, Rome RM, Fortune DW (1986) Low malignant potential tumors of the ovary: a study of 76 cases. Obstet Gynecol 68: 338–44

    CAS  PubMed  Google Scholar 

  59. Nation JG, Krepart GV (1986) Ovarian carcinoma of low malignant potential: Staging and treatment. Am J Obstet Gynecol 154: 290–3

    CAS  PubMed  Google Scholar 

  60. O’Quinn AG, Hannigan EV (1985) Epithelial ovarian neoplasms of low malignant potential. Gynecol Oncol 21: 177–85

    CAS  Google Scholar 

  61. Barakat RR, Benjamin I, Lewis JL Jr et al. (1995) Platinum-based chemotherapy for advanced-stage serous ovarian carcinoma of low malignant potential. Gynecol Oncol 59: 390–3

    Article  CAS  PubMed  Google Scholar 

  62. Fort MG, Pierce VK, Saigo PE et al. (1989) Evidence of the efficacy of adjuvant therapy in epithelial ovarian tumors of low malignant potential. Gynecol Oncol 32: 269–72

    Article  CAS  PubMed  Google Scholar 

  63. Benjamin I, Barakat R, Hakes T et al. (1994) Platinum-based chemotherapy for advanced stage ovarian serous carcinoma of low malignant potential. Proc Ann Meet Am Soc Clin Oncol 13: Abstract no 834

    Google Scholar 

  64. Barnhill D, Kurman RJ, Brady MF et al. (1995) Preliminary analysis of the behavior of stage I ovarian serous tumors of low malignant potential: a Gynecologic Oncology Group study. J Clin Oncol 13(11): 2752–6

    CAS  PubMed  Google Scholar 

  65. Elias D, Sabourin JC (1999) FrPseudomyxome péritonéal. Revue de la littérature. J Chir 136: 341–7

    CAS  Google Scholar 

  66. Wertheim I, Fleischhaker D, McLachlin CM et al. (1994) Pseudomyxoma peritonei: a review of 23 cases. Obstet Gynecol 84(1): 17–21

    CAS  PubMed  Google Scholar 

Download references

Authors
  1. C. Lhommé
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Pautier
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Morice
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Castaigne
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. Pomel
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Rey
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. C. Balleyguier
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. C. Haie-Meder
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. P. Duvillard
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag France

About this chapter

Cite this chapter

Lhommé, C. et al. (2006). Place de la chimiothérapie dans le traitement des tumeurs de l’ovaire à la limite de la malignité. In: Les cancers ovariens. Abord clinique. Springer, Paris. https://doi.org/10.1007/2-287-30921-7_34

Download citation

  • DOI: https://doi.org/10.1007/2-287-30921-7_34

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-25168-9

  • Online ISBN: 978-2-287-30921-2

Publish with us

Policies and ethics

Search

Navigation